Evaluation of Primary Plating in Sternotomy Patients for Osteosynthesis and Pain
NCT ID: NCT00819286
Last Updated: 2018-02-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2008-11-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sternal Closure With SternaLock 360: First in Man Study
NCT02686099
Titanium vs. PEEK Fusion Devices in 1 Level TLIF
NCT05691062
Evaluation of the Efficacy and Safety of Absorbable vs Traditional Bone Wax for Facet Fusion After Lumbar Fusion Surgery
NCT07040293
Clinical Outcome and Fusion Results Using the VerteLoc® Facet Fixation Device
NCT01892878
Study Comparing Postoperative Treatment After Surgical Decompression for Lumbar Spinal Stenosis.
NCT05312281
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
wire (control)
patients will have their sternum closed using wire (stainless steel surgical wire).
wire (control)
patients will have their sternum closed using wire (stainless steel surgical wire).
SternaLock Rigid Fixation Plates
patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates.
SternaLock Rigid Fixation Plates
patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SternaLock Rigid Fixation Plates
patients will have their sternum closed by rigid fixation using SternaLock Rigid Fixation Plates
wire (control)
patients will have their sternum closed using wire (stainless steel surgical wire).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients eighteen (18) years of age or older;
* Patients presenting two or more risk factors such as diabetes mellitus, Chronic Obstructive Pulmonary Disease, obesity (BMI \> 30), osteoporosis, Renal failure, Chronic steroid use, Immunosuppression, Redo sternotomy, Neurologic dysfunction severely affecting ambulation,
* Off mid-line sternotomy
* bilateral IMA use
* Long cardio-pulmonary bypass runs
* Transverse fractures of the sternum
Exclusion Criteria
* Patients with an off-midline sternotomy that reduced the bony margin to \<2mm
* Patients under eighteen (18) years of age;
* Patients that are pregnant or currently lactating;
* Patients presenting intra-operative conditions that would require the use of rigid fixation and/or additional post-sternotomy mechanical support beyond wire cerclage due to surgical evaluation,
* Patients defined within the New York Heart Association (NYHA) or Canadian Cardiovascular Society (CCS) functional Class IV for congestive heart failure,
* Patients presenting emergent/salvage cardiac acuity as defined per the Society of Thoracic Surgeons (STS) guidelines: i.e., patients undergoing cardiopulmonary resuscitation en route to the operating room or prior to induction of anesthesia;
* Patients undergoing post-operative revision procedures that treat the original sternotomy in such a way as to affect outcome (antibiotic irrigation, debridement or other treatment to the osteotomy);
* Patients unwilling or unable to return for follow-up;
* Lacking the ability to follow instructions;
* Intraoperative death.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zimmer Biomet
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jai Raman, MD
Role: STUDY_CHAIR
University of Chicago
Michael Wong, MD
Role: PRINCIPAL_INVESTIGATOR
University of California Davis Medical Center, Sacramento, CA
Brian DeGuzmann, MD
Role: PRINCIPAL_INVESTIGATOR
St. Joseph's Medical Center, Phoenix, AZ
Sven Lehmann, MD
Role: PRINCIPAL_INVESTIGATOR
Leipzig Heart Center, Leipzig, Germany
Kenton Zehr, MD
Role: PRINCIPAL_INVESTIGATOR
Scott & White Memorial Hospital, Temple, TX
H Edward Garrett, Jr, MD
Role: PRINCIPAL_INVESTIGATOR
Baptist Memorial Hospital, Memphis, TN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Joseph's Heart and Lung Institute
Phoenix, Arizona, United States
University of California Davis Medical Center
Sacramento, California, United States
University of Chicago
Chicago, Illinois, United States
Baptist Memorial Hospital
Memphis, Tennessee, United States
Scott & White Memorial Hospital
Temple, Texas, United States
Leipzig Heart Center
Leipzig, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07071
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.